golimumab
janssen,merck
['golimumab', 'axspa']
 abs 0545 weinstein, et al
phase 4 rct, golimumab withdrawal in nr-axspa
n=188
randomized to: continued gol, reduced gol q2m, withdrawal #acr22
@bu_bmc_rheum | @rheum_covid @spartan_updates @official_asas | @UWRheum @UWEpidemiology 2020 | @OHSUIMres 2017 | @UTMBhealth 2014 | @UTAustin 2010